Blog
Virtual Wholesaling
It is common in today’s rapidly evolving pharmaceutical sector that companies need to outsource key activities. This can be for a number of reasons including specialist expertise, specialist storage facilities, capacity of both facilities and people, cost to your organisation and time.
Pharmacy Regulatory changes
There have been several Pharmacy Regulatory changes which will come into force on the 23rd June 2025. Are you ready for them? Firstly, the market entry for Distance Selling models is closing, if you are contemplating a Distance Selling Pharmacy, the application must...
Distance selling Pharmacy market entry is closing on 23rd June 2025
The market entry process for distance selling pharmacies is closing on 23rd June 2025. Having been laid before parliament on the 2nd of June changes to the community pharmacy sector will come into force in 21 days.
Considerations for Quality Agreements
It is common in today’s rapidly evolving pharmaceutical sector that companies need to outsource key activities. This can be for several reasons including specialist expertise, specialist storage facilities, capacity of both facilities and people, cost to your organisation and time.
GDP certificates do not expire
GDP certificates are not being automatically extended to the end of 2025 if they are approaching their expiry or have already expired.
Parallel Trade – A reminder
Following a government consultation, updated guidance on the application and implications of Intellectual Property (IP) restrictions has been published. Essentially there is no change to the rules that were established following Brexit, but it is important for businesses who participate in this trading style are aware of the rules.
Journalists – Be Careful What You Write About Medicines
The MHRA continue to scrutinise and take action against Pharmacies and Clinics who are promoting Prescription Only Medicines (POMs) to the public. However, this month’s advertising investigations bulletin also includes action against a journalist newspaper article.
Responsible Person for Import Role after the Windsor Framework
The Responsible Person for Import (RPi) is an important role to maintain oversight of the supply chain of medicines imported for use in the UK.
Emerging Risks in Pharmacy Practice: Key Updates from the GPhC
In this blog I want to highlight some critical updates from the General Pharmaceutical Council (GPhC) that every pharmacy professional—whether you’re a pharmacist, technician, or pharmacy owner—should be aware of. These issues have prompted serious regulatory concerns and demand thoughtful consideration and action where appropriate.
Risk Assessments for Registered Pharmacies Providing Pharmacy Services at a Distance
Risk Assessments are a regulatory requirement in medicines wholesaling but have you considered that they could also be very useful in pharmacy practice?
New Best practice guidance on the sale of medicines for pain relief
The MHRA have updated their Blue Guide on Advertising and Promoting Medicines. The update is to Appendix 4 with new Best Practice guidance on the sale of medicines for pain relief.
Advertising Prescription Only Medicines (POM): Do you know the rules?
Are you advertising Prescription Only Medicines (POM) utilising a prescribing service? Do you know it is illegal to advertise a POM?